Home
Conditions
Waldenstrom Macroglobulinemia

Clinical trial condition

Waldenstrom Macroglobulinemia

Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.

395 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinemia trial results

Completed

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

NCT00448357

Conditions: Blast Crisis, Blood Coagulation Disorders, Blood Platelet Disorders, +72 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

NCT00058240

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +25 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

NCT00072514

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy

NCT02381080

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +28 more
Locations: N/a N/a, Canada

Moscow, Russia

Petrozavodsk, Russia

Saint Petersburg, Russia

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia

NCT00811733

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Stanford, California, United States

GSK Investigational Site Rochester, Minnesota, United States

GSK Investigational Site Buffalo, New York, United States

View Trial Details

Completed

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

NCT00376922

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00118352

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

University of Torino Torino, Italy

View Trial Details

Completed

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

NCT00899496

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +122 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

NCT00601718

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +83 more
Locations: Puget Sound Oncology Consortium Seattle, Washington, United States

View Trial Details

Waldenstrom Macroglobulinemia

Waldenstrom Macroglobulinemia trial results

Related conditions